Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,984
Total Claims
$1.6M
Drug Cost
834
Beneficiaries
$1,968
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-10%
Opioid rate vs peers
2.3% vs 2.6% avg
+84%
Cost per patient vs peers
$1,968 vs $1,068 avg
+88%
Brand preference vs peers
16.9% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.3%
Opioid Rate
256
Opioid Claims
$2,458
Opioid Cost
5.5%
Long-Acting Rate
Brand vs Generic
Brand: 1,830 claims · $1.4M
Generic: 8,992 claims · $196K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 160 | $219K |
| Dulaglutide | 114 | $145K |
| Tirzepatide | 96 | $141K |
| Empagliflozin | 88 | $91K |
| Apixaban | 91 | $84K |
| Fluticasone/Umeclidin/Vilanter | 65 | $65K |
| Insulin Glargine,hum.Rec.Anlog | 95 | $65K |
| Sitagliptin Phosphate | 37 | $58K |
| Insulin Pump Cart,cont Inf,bt | 31 | $51K |
| Rivaroxaban | 46 | $41K |
| Insulin Glargine,hum.Rec.Anlog | 17 | $32K |
| Insulin Lispro | 27 | $27K |
| Linagliptin | 23 | $26K |
| Umeclidinium Brm/Vilanterol Tr | 30 | $25K |
| Mirabegron | 18 | $22K |
Prescribing Profile
Patient Profile
71
Avg Age
54%
Female
2.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About